More Frequent Dosing of Interferon Beta-1a May Benefit Patients With MS With Breakthrough DiseaseJune 5, 2018Multiple Sclerosis
Ocrelizumab’s Benefits on Confirmed Disability Improvement Persist in Open-Label ExtensionJune 5, 2018Multiple Sclerosis
How Does the Gut Microbiome Differ in Patients With Relapsing MS Versus Controls?June 1, 2018Multiple Sclerosis
A Mediterranean Diet May Be Associated With Lower Depression and Cognitive Impairment Scores in Patients With MSJune 1, 2018Multiple Sclerosis
